Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;81(2):291-293.
doi: 10.1136/annrheumdis-2021-221206. Epub 2021 Sep 7.

Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

Affiliations

Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

Caoilfhionn M Connolly et al. Ann Rheum Dis. 2022 Feb.
No abstract available

Keywords: COVID-19; autoimmune diseases; epidemiology; vaccination.

PubMed Disclaimer

Conflict of interest statement

Competing interests: DLS has the following financial disclosures: consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, Thermo Fisher Scientific. LC-S has the following financial disclosures: consultant fees from Janssen, Boehringer-Ingelheim, Mallinckrodt, EMD-Serono, Allogene and ArgenX.

References

    1. Connolly CM, Boyarsky BJ, Ruddy JA et al. Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series. Ann Intern Med. 2021. May 25. doi: 10.7326/M21-1451. Epub ahead of print. - DOI - PMC - PubMed
    1. Ruddy JA, Connolly CM, Boyarsky BJ, et al. High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseasesAnnals of the Rheumatic Diseases Published Online First: 24 May 2021. doi: 10.1136/annrheumdis-2021-220656 - DOI - PMC - PubMed
    1. Brosh-Nissimov T, Orenbuch-Harrouch E, Chowers M et al. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated COVID-19 patients in Israel. Clinical Mircobiology and Infection. In press - PMC - PubMed
    1. Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021. Jun 23:NEJMc2108861. doi: 10.1056/NEJMc2108861. Epub ahead of print. - DOI - PMC - PubMed
    1. Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021. Jun 15:L21–0282. doi: 10.7326/L21-0282. Epub ahead of print. - DOI - PMC - PubMed

Publication types